The Relationship between Obesity and Serum 1,25-Dihydroxy Vitamin D Concentrations in Healthy Adults
Top Cited Papers
- 1 March 2004
- journal article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 89 (3) , 1196-1199
- https://doi.org/10.1210/jc.2003-031398
Abstract
Several previous reports of small cohorts have found significantly higher serum 1,25-dihydroxy vitamin D (1,25-vit D) in obese compared with nonobese whites. Based on these reports and on recent in vitro studies of adipocytes which suggest that administration of 1,25-vit D can stimulate lipogenesis and inhibit lipolysis, some investigators have proposed that high 1,25-vit D may play a role in promoting or maintaining adipocyte triglyceride stores in obese adults. To test the hypothesis that obesity is commonly associated with increased 1,25-vit D, we examined the relationships between calciotropic hormones and body adiposity in a large cohort of healthy adults. Serum intact PTH, 25-hydroxy vitamin D, and 1,25-vit D were measured in the postabsorptive state in 302 healthy adults who were Caucasian (n = 190; 71% female), African-American (n = 84; 89% female), and of other race/ethnicity (n = 28; 61% female). Results from the 154 obese subjects [body mass index (BMI) 37.3 ± 5.8 kg/m2; range, 30.1–58.2 kg/m2] were compared with those from 148 nonobese (BMI 25.6 ± 2.9 kg/m2; range, 18.0–29.9 kg/m2) age-, race-, and sex-matched participants. Body composition was measured by dual energy x-ray absorptiometry. Serum intact PTH was positively correlated with both BMI (r = 0.42; P < 0.0001) and body fat mass (r = 0.37; P < 0.0001). Serum 25-hydroxy vitamin D was negatively correlated with BMI (r = −0.4; P < 0.0001) and body fat mass (r = −0.41; P < 0.0001). Serum 1,25-vit D was also negatively correlated with BMI (r = −0.26; P < 0.0001) and body fat mass (r = −0.25; P = 0.0001). Serum 1,25-vit D was significantly lower in obese than nonobese subjects (105.7 ± 41.1 vs. 124.8 ± 36.7 pmol/liter; P < 0.0001) in both Caucasian and African-American adults. We conclude that, because 1,25-vit D concentrations fall with increasing adiposity, it appears unlikely that elevation in 1,25-vit D is an important hormonal mechanism causing or maintaining obesity in adults.Keywords
This publication has 20 references indexed in Scilit:
- Body Fat Content and 25-Hydroxyvitamin D Levels in Healthy WomenJournal of Clinical Endocrinology & Metabolism, 2003
- Regulation of Adiposity and Obesity Risk By Dietary Calcium: Mechanisms and ImplicationsJournal of the American College of Nutrition, 2002
- 1α,25‐Dihydroxyvitamin D3modulates human adipocyte metabolism via nongenomic actionThe FASEB Journal, 2001
- Decreased bioavailability of vitamin D in obesityThe American Journal of Clinical Nutrition, 2000
- Regulation of adiposity by dietary calciumThe FASEB Journal, 2000
- Endocrine aspects of obesityThe Netherlands Journal of Medicine, 1995
- Low circulating vitamin D in obesityCalcified Tissue International, 1988
- Mineral Metabolism in Obese ChildrenActa Paediatrica, 1988
- Evidence for alteration of the vitamin D-endocrine system in obese subjects.Journal of Clinical Investigation, 1985
- Vitamin D status and bone histomorphometry in gross obesityThe American Journal of Clinical Nutrition, 1981